Mohammad Saleh Rabiee

I work at the intersection of biotechnology and commercial strategy — the point where the science of a molecule meets the realities of bringing it to a market. My foundation is scientific. I am training as a biotechnologist at the doctoral level, which shapes how I approach the commercial side of this industry: I tend to read a partnership, a pipeline, or a market the way I would read a scientific problem — looking for what holds up under scrutiny and what only looks good on the surface. Today my focus is business development in the biopharmaceutical space, with particular attention to biosimilars, monoclonal antibodies, and technology transfer. Much of my work involves understanding markets across the GCC and the wider MENA region that are not well documented from the outside — assessing their real dynamics, evaluating potential partners, and thinking through how a product actually reaches the patient, not just how it is supposed to on paper. I am drawn to this work because it rewards both rigor and judgment. The technical questions matter, but so do the commercial ones, and the most interesting decisions sit where the two can't be separated. I am always open to connecting with others working across science, manufacturing, and the business of biopharma.